![Melissa Downs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Melissa Downs is currently Executive Director-External Communications at Lantheus Holdings, Inc. since 2025.
Formerly, Ms. Downs worked at Progenics Pharmaceuticals, Inc. as Investor Relations Contact.
Postes actifs de Melissa Downs
| Sociétés | Poste | Début |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 01/08/2020 |
Anciens postes connus de Melissa Downs
| Sociétés | Poste | Fin |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Lantheus Holdings, Inc.
 Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
